Skip to main content
. Author manuscript; available in PMC: 2020 Jun 26.
Published in final edited form as: J Med Chem. 2020 Jan 14;63(3):1216–1232. doi: 10.1021/acs.jmedchem.9b01566

Figure 6.

Figure 6.

Compounds 6 and 10 potently reduced protein levels of EGFR mutants and inhibited downstream signaling in lung cancer cells. NSCLC cell lines HCC-827 (A) and H3255 (B) were cultured to 80% confluent and then switched to a serum-free medium for 8 h before treating with indicated concentrations of the compounds for another 16 h. EGFR e19d: EGFR mutant with exon 19 deletion; EGFR L858R: EGFR L858R single point mutant; Gef: gefitinib (parental EGFR inhibitor; 1 μM); 1k: 1000; 10k: 10 000.